154 related articles for article (PubMed ID: 36043778)
1. GLP-1 Targeted Novel 3-phenyl-7-hydroxy Substituted Coumarins Mitigate STZ-induced Pancreatic Damage and Improve Glucose Homeostasis in OGTT Method.
Gupta MK; Srivastava R; Kumar S; Varshney KK; Singh H
Protein Pept Lett; 2022; 29(11):979-992. PubMed ID: 36043778
[TBL] [Abstract][Full Text] [Related]
2. Novel coumarin modified GLP-1 derivatives with enhanced plasma stability and prolonged in vivo glucose-lowering ability.
Han J; Sun L; Huang X; Li Z; Zhang C; Qian H; Huang W
Br J Pharmacol; 2014 Dec; 171(23):5252-64. PubMed ID: 25039358
[TBL] [Abstract][Full Text] [Related]
3. Coumarin-chalcone hybrids targeting insulin receptor: Design, synthesis, anti-diabetic activity, and molecular docking.
Konidala SK; Kotra V; Danduga RCSR; Kola PK
Bioorg Chem; 2020 Nov; 104():104207. PubMed ID: 32947135
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic Activity of Dihydropyrimidine Scaffolds and Structural Insight by Single Crystal X-ray Studies.
Bairagi KM; Younis NS; Emeka PM; Sangtani E; Gonnade RG; Venugopala KN; Alwassil OI; Khalil HE; Nayak SK
Med Chem; 2020; 16(7):996-1003. PubMed ID: 31880253
[TBL] [Abstract][Full Text] [Related]
5. Novel hybrids of benzothiazole-1,3,4-oxadiazole-4-thiazolidinone: Synthesis, in silico ADME study, molecular docking and in vivo anti-diabetic assessment.
Bhutani R; Pathak DP; Kapoor G; Husain A; Iqbal MA
Bioorg Chem; 2019 Mar; 83():6-19. PubMed ID: 30339863
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization, biological evaluation and docking of coumarin coupled thiazolidinedione derivatives and its bioisosteres as PPARγ agonists.
Shukla S; Kumar P; Das N; Moorthy NS; Shrivastava SK; Trivedi P; Srivastava RS
Med Chem; 2012 Sep; 8(5):834-45. PubMed ID: 22741802
[TBL] [Abstract][Full Text] [Related]
7. Antidiabetic activity of benzopyrone analogues in nicotinamide-streptozotocin induced type 2 diabetes in rats.
Nayak Y; Hillemane V; Daroji VK; Jayashree BS; Unnikrishnan MK
ScientificWorldJournal; 2014; 2014():854267. PubMed ID: 25548795
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
Musoev A; Numonov S; You Z; Gao H
Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
Patel BD; Bhadada SV; Ghate MD
Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
[TBL] [Abstract][Full Text] [Related]
10. Rational design of dimeric lipidated Xenopus glucagon-like peptide 1 analogues as long-acting antihyperglycaemic agents.
Han J; Huang Y; Chen X; Zhou F; Fei Y; Fu J
Eur J Med Chem; 2018 Sep; 157():177-187. PubMed ID: 30096651
[TBL] [Abstract][Full Text] [Related]
11. Coumarin-based Scaffold as α-glucosidase Inhibitory Activity: Implication for the Development of Potent Antidiabetic Agents.
Tafesse TB; Bule MH; Khoobi M; Faramarzi MA; Abdollahi M; Amini M
Mini Rev Med Chem; 2020; 20(2):134-151. PubMed ID: 31553294
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, Antioxidant and Antiproliferative Evaluation, Molecular Docking and DFT Studies of Some Novel Coumarin and Fused Coumarin Derivatives.
Gouda MAS; Salem MAI; Marzouk MI; Mahmoud NFH; Ismail MF
Chem Biodivers; 2023 Jul; 20(7):e202300706. PubMed ID: 37321977
[TBL] [Abstract][Full Text] [Related]
13. Design and Synthesis of Novel Coumarin Conjugated Acetamides as Promising Anticancer Agents: An In Silico and In Vitro Approach.
Mamatha SV; Belagali SL; Bhat M; Kumbar VM
Anticancer Agents Med Chem; 2021; 21(11):1431-1440. PubMed ID: 32664844
[TBL] [Abstract][Full Text] [Related]
14. Coumarins from Angelica decursiva inhibit α-glucosidase activity and protein tyrosine phosphatase 1B.
Ali MY; Jannat S; Jung HA; Jeong HO; Chung HY; Choi JS
Chem Biol Interact; 2016 May; 252():93-101. PubMed ID: 27085377
[TBL] [Abstract][Full Text] [Related]
15. Facile Synthesis of Novel Coumarin Derivatives, Antimicrobial Analysis, Enzyme Assay, Docking Study, ADMET Prediction and Toxicity Study.
Tiwari SV; Seijas JA; Vazquez-Tato MP; Sarkate AP; Karnik KS; Nikalje APG
Molecules; 2017 Jul; 22(7):. PubMed ID: 28703783
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, molecular modelling studies and ADME prediction of benzothiazole clubbed oxadiazole-Mannich bases, and evaluation of their anti-diabetic activity through in vivo model.
Bhutani R; Pathak DP; Kapoor G; Husain A; Kant R; Iqbal MA
Bioorg Chem; 2018 Apr; 77():6-15. PubMed ID: 29316509
[TBL] [Abstract][Full Text] [Related]
17. A Review of Coumarins and Coumarin-Related Compounds for Their Potential Antidiabetic Effect.
Ranđelović S; Bipat R
Clin Med Insights Endocrinol Diabetes; 2021; 14():11795514211042023. PubMed ID: 35173509
[TBL] [Abstract][Full Text] [Related]
18. Coumarin and 3,4-dihydroquinolinone derivatives: Synthesis, antidepressant activity, and molecular docking studies.
Wang SB; Liu H; Li GY; Li J; Li XJ; Lei K; Wei LC; Quan ZS; Wang XK; Liu RM
Pharmacol Rep; 2019 Dec; 71(6):1244-1252. PubMed ID: 31670061
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a novel GLP-1/GIP dual receptor agonist CY-5 as long-acting hypoglycemic, anti-obesity agent.
Liu C; Li C; Cai X; Zou Y; Mo J; Chen B; Cai Y; Han T; Huang W; Qian H; Zhang W
Bioorg Chem; 2021 Jan; 106():104492. PubMed ID: 33268008
[TBL] [Abstract][Full Text] [Related]
20. Hypoglycemic properties of some preparations and compounds from Artemisia ludoviciana Nutt.
Anaya-Eugenio GD; Rivero-Cruz I; Rivera-Chávez J; Mata R
J Ethnopharmacol; 2014 Aug; 155(1):416-25. PubMed ID: 24892833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
